(Q36815269)

16 August 2017

1 reference

title

The overactive bladder syndrome: treating patients on an individual basis (English)

1 reference

16 August 2017

Linda Cardozo

1

1 reference

16 August 2017

language of work or name

1 reference

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

99 Suppl 3

1 reference

16 August 2017

page(s)

1-7

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

Urinary habits among asymptomatic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

Muscarinic receptor subtypes and management of the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06698.X

10.1111/J.1464-410X.2007.06698.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference